People
Scientists, clinicians, regulatory specialists, and business leaders working together across discovery, development, quality, and clinical translation.
Dr. Li develops botanical medicines for allergic and inflammatory conditions, with an emphasis on translating laboratory discoveries into practical applications and evidence-based clinical outcomes. Her work in food allergy, asthma, eczema, and integrative health has resulted in more than 100 peer-reviewed publications.
Mr. Xue oversees talent and resource development for GNT’s botanical drug programs. He earned a BS in Chemical Engineering Technology from Zhengzhou University and an MS in Biotechnology from Johns Hopkins University, with additional training in international business and economics.
Dr. Yang leads analytical chemistry and quality control work at GNT. His expertise includes HPLC, LC-MS, immunobiology, molecular biology, and pharmacokinetic analysis in animal models and human studies. He serves as principal investigator for GNT’s SBIR/STTR awards, supports multiple NIH programs, serves as a primary FDA liaison for IND work, and oversees CMC data for clinical development programs.
Ms. Grzybowski brings experience in operations, human resources, corporate wellness, and business consulting. At GNT, she has led the Dietary Food Tolerance Program and work on tolerogenic food products intended for use as foods or dietary supplements. She also helps pursue investment, strategic partnerships, and licensing opportunities that can advance GNT’s programs.
Dr. Carnazza earned her doctorate in Pathology, Microbiology and Immunology in 2024. At GNT, she applies bioinformatics, microbiology, gene editing, molecular biology, in vitro systems, and animal models of food allergy to evaluate the efficacy and safety of natural compounds and combination approaches.
Jake earned a BS in Chemistry from Ramapo College of New Jersey and conducted graduate research in synthetic chemistry and enzyme mechanisms at the University of Florida. At GNT, he develops, prepares, and tests eczema formulations while supporting product quality, safety, and regulatory compliance.
Dr. Srivastava reviews nonclinical and clinical research, including animal-model studies and work involving patient samples, and supports IACUC and IRB submissions. She contributes expertise in immunology, allergy, cell and molecular biology, physiology, and IND-related research.
Dr. Sampson is an internationally recognized food allergy researcher with extensive experience in clinical study design and interpretation. He has collaborated with Dr. Li on herbal formula trials and has advised GNT’s NIH and SBIR work.
Dr. Zhang is a New York-based registered dietitian nutritionist, licensed dietitian, certified lactation counselor, and trained Low-FODMAP practitioner. She earned a PhD in Behavioral Nutrition from Teachers College, Columbia University.
Dr. Chung is board certified in allergy and immunology, internal medicine, and integrative medicine. She has helped lead East-West integrative medicine programming and has collaborated with Dr. Li in patient care and traditional Chinese medicine publications.
Dr. Dunkin is a board-certified pediatric gastroenterologist and associate professor at the Icahn School of Medicine at Mount Sinai. His research with Dr. Li addresses gastrointestinal allergic disorders and Chinese herbal medicines for IBD and eosinophilic esophagitis.
Mr. Schlessinger founded Encore Books and Zany Brainy and co-founded Five Below, where he served as executive chairman. He advises GNT on strategy, business operations, investor engagement, partnerships, and licensing opportunities and has supported research into IgE-inhibitory natural compounds.
Mr. Ehrlich is an author and former professional speechwriter. He has written and co-authored books about food allergy, allergic disease, eczema, and traditional Chinese medicine, and supports GNT correspondence, social media, and public relations.
